Meet the patent and licensing experts who step in when St. Jude inventions and technologies need to be developed into drugs, therapies, and other tangible products to help patients worldwide.
Read More
Water can make all the difference when it comes to helping ensure a protein can do its job.
Read More
Latent Cellular Analysis will enable researchers to wade through large amounts of single-cell RNA sequencing data and derive insights into cellular machinery.
Read More
The 2019-20 flu season is on. Richard Webby, PhD, has heard and debunked every excuse for avoiding or delaying a flu shot. His advice is both credible and personal. He and his St. Jude Infectious Diseases colleagues help to decide what goes into the world’s influenza vaccines.
Read More
We’re in an era where genetic sequencing is more accessible than ever. Some people do it for...
Read More
Researchers know small molecules called cytokines fuel the fire that drives the life-threatening...
Read More
How can the same drug used to treat the same disease in two patients can cause drastically different results and what drives these differences?
Read More
Just in time for the flu season comes news that federal health officials are pumping millions into...
Read More
Molecules called chaperones are the first line of defense against proteins going “bad” in cells....
Read More
Preclinical research helps lead to clinical trial for pediatric brain tumor treatment.
Read More
Findings from rare pediatric genetic diseases offer insights into common diseases of aging, like Alzheimer’s and fibrosis.
Read MoreEric Enemark, PhD, best explains the complicated process of cells beginning to divide by showing how DNA replicates via this simple contraption.
Read More
